a, USV index (n=27/29
(PBS;male/female); n=28/21 (Poly(I:C);male/female);
6 independent experiments). b-c, Total investigation time
(b) and total distance traveled (c) during the
sociability test (n=13/15 (vehicle;PBS/poly(I:C));
n=12/16 (vancomycin;PBS/poly(I:C)); 3-4
independent experiments). d, Schematic of the experimental
design. e-f, Quantification of SATB2+ cells
(e) in the cortex divided into ten equal bins representing
different depths of the cortex or of the cortical patch size
(f) in the primary somatosensory cortex (S1)
(n=3/4 (PBS;vehicle/vancomycin);
n=3/4 (poly(I:C);vehicle/vancomycin); 2
independent experiments). g, Flow cytometry of
CD4+ T cells (gated on
TCR-β+CD4+) stained
intracellularly for IL-17a and RORγt. Mononuclear cells were
collected at E14.5 from the ilea of poly(I:C)-treated mice with/without
vancomycin treatment; Representative FACS plot from 3 independent
experiments. h, qPCR analysis measuring relative SFB levels in
B6 mice before/after vancomycin treatments
(n=4-5/group). i, Representative SEM
images of epithelial surfaces in the ilea of the vehicle-/vancomycin-treated
mice from 2 independent experiments. Scale bars, 30 μm.
*p<0.05,
**p<0.01,
***p<0.001,
****p<0.0001 as
calculated by two-way (a,e) and one-way
(b,c,f) ANOVA with Tukey post-hoc
tests. N.D., not determined; N.S., not significant. Graphs indicate mean
+/− s.e.m.